Dr Nigam agrees to doubling slick NW6/NW7
Collapse
X
-
This is a completely false statement. When you work for a start-up biotech company you make very little in terms of salary, most compensation is paid out in ownership and stock options. The incentive in working for a biotech start-up is to develop something that can be sold to big pharma and cash in a big pay day. What your claiming is the exact opposite of what the reality is in the industry. -
Same with Aderans. Histogen seem to be the only ones making progress.
Deressing times.Leave a comment:
-
I cant believe how Replicel hasnt started Phase II yet - didnt they say they were going to start mid-2013?
If all goes to plan they will have only completed phase II by 2017 - what a JOKE!Leave a comment:
-
Probably because English is his second (or third or tenth) language, which no doubt contributes to your perception of him being "without a doubt, the dumbest frequent poster on these boards."
I'm sure if you posted on a forum that was published in a language that you weren't completely familiar with, you would also sound quite dumb to native or fluent speakers.Leave a comment:
-
-
-
because some upolite people here started talking rude to him i believe....but Dr we are still people that respect you here and need to hear from you....Leave a comment:
-
-
Nigam is dead?
Why not write more updates. First always wrote to talk about anything, now that should give conclusive evidence there has never ...Leave a comment:
-
-
-
-
Hehe. It's amazing how quickly a thread can completely derailLet's get back on topic guys. No response yet from Dr Nigams to my idea, hopefully he'll do so soon, otherwise I'll just send him an email and see what he says. We need to find out if this works !
Leave a comment:
Leave a comment: